4.2 Article

Continuous corticosterone delivery via the drinking water or pellet implantation: A comparative study in mice

Journal

STEROIDS
Volume 116, Issue -, Pages 76-82

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2016.10.008

Keywords

Hypercortisolism; Corticosterone delivery; Glucocorticoid-induced dysmetabolism; Insulin-resistance; Sarcopenia; Osteoporosis

Funding

  1. NHMRC project [APP1086100]
  2. Australian government for Australian Postgraduate Award
  3. Humboldt University/Charite University Medicine, Berlin

Ask authors/readers for more resources

In order to investigate the effects of glucocorticoid excess in rodent models, reliable methods of continuous glucocorticoid delivery are essential. The current study compares two methods of corticosterone (CS) delivery in regards to their ability to induce typical adverse outcomes such as fat accrual, insulin resistance, sarcopenia and bone loss. Eight-week-old mice received CS for 4 weeks either via the drinking water (25-100 mu tg CS/mL) or through weekly surgical implantation of slow release pellets containing 1.5 mg CS. Both methods induced abnormal fat mass accrual, inhibited lean mass accretion and bone expansion, suppressed serum osteocalcin levels and induced severe insulin resistance. There was a clear dose dependant relationship between the CS concentrations in the drinking water and the severity of the phenotype, with a concentration of 50 mu g CS/mL drinking water most closely matching the metabolic changes induced by weekly pellet implantations. In contrast to pellets, however, delivery of CS via the drinking water resulted in a consistent diurnal exposure pattern, closely mimicking the kinetics of clinical glucocorticoid therapy. In addition, the method is safe, inexpensive, easily adjustable, non-invasive and avoids operative stress to the animals. Our data demonstrate that delivery of CS via the drinking water has advantages over weekly implantations of slow-release pellets. A dose of 50 mu g CS/mL drinking water is appropriate for the investigation of chronic glucocorticoid excess in mice. Crown Copyright (C) 2016 Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available